U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  5. A Pandemic and a Call to Action for One Health: The FDA One Health Initiative - 06/11/2020 - 06/11/2020
  1. FDA Grand Rounds

Webcast

Event Title
A Pandemic and a Call to Action for One Health: The FDA One Health Initiative
June 11, 2020


Date:
June 11, 2020
Time:
12:00 PM - 1:00 PM ET


CE Credit Available

About the Presentation:

The Food and Drug Administration (FDA) is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. There are many factors that pose risks or threaten public health. FDA’s efforts to improve health goes beyond recognizing disease transmission in an isolated lens of human health, but also acknowledges human-animal interactions and associated environmental factors such as socioeconomic status, behavior, and other social determinants. Addressing human and animal intersectoral factors that are both biological and environmental is a complex endeavor requiring a great deal of knowledge, skills, and resources from various disciplines. However, as health disciplines become progressively specialized, they also become more siloed. One Health is a concept that embraces a multisectoral and transdisciplinary approach to solving health problems by recognizing the interconnection between humans, animals, and their shared environment. Many global changes and activities associated with increased human-animal interactions are enabling disease transmission that become epidemics or pandemics that adversely impact public health. This presentation will explain the One Health Concept and the FDA One Health Initiative. It will also highlight the benefits of One Health and how FDA is operationalizing One Health actions Agency-wide.

What you’ll learn about FDA’s One Health Initiative:

  • Explain the mission and goals of the FDA One Health Initiative.
  • Identify recent FDA One Health Initiative related activities.
  • Discuss why a One Health approach to pandemics is the new norm.

Co-Presented by:

  • Bernadette Dunham, D.V.M., Ph.D. Professorial Lecturer, Milken Institute School of Public Health, George Washington University, Advisor to the FDA One Health Initiative, Center for Veterinary Medicine, FDA.   
  • CAPT Brianna Skinner, D.V.M., M.P.H., DACLAM CAPT, USPHS, Senior Regulatory Veterinarian, Office of the Commissioner, Office of Counterterrorism and Emerging Threats, FDA.

About the Speakers:
Bernadette Dunham, D.V.M., Ph.D.
Professorial Lecturer, Milken Institute School of Public Health, George Washington University.
Advisor to the FDA One Health Initiative, Center for Veterinary Medicine, FDA.

Biography:

Dr. Bernadette Dunham is with the Milken Institute School of Public Health at George Washington University (2016 to present) where her focus is on One Health issues. In October 2019, Dr. Dunham was appointed as a member of the National Academies of Sciences, Engineering and Medicine's Board on Agriculture and Natural Resources for a three-year term thru December 2022. Dr. Dunham returned to the FDA in August 2019 to serve as an Advisor to the FDA One Health Initiative. Dr. Dunham has served the FDA as Director of the Center for Veterinary Medicine (CVM) from 2008-2016, Deputy Director of CVM and Director of the Office of Minor Use and Minor Species from 2006-2008, and Deputy Director of the Office of New Animal Drug Evaluation from 2002-2006.  Before beginning her government career, she was an Assistant Director with American Veterinary Medical Association’s Governmental Relations Division in Washington, D.C. from 1995-2002. Dr. Dunham served as Director of Laboratory Medicine and Adjunct Professor of Pharmacology at the State University of New York Health Science Center, Syracuse, N.Y. from 1987-1995.  Before returning to academy in 1979 to pursue her Ph.D. and Post-Doctoral research in cardiovascular pathophysiology at Boston University, Dr. Dunham was in private veterinary practice for four years in Oshawa, Ontario, Canada. Dr. Dunham received her D.V.M. degree from the Ontario College of Veterinary Medicine, University of Guelph, Canada and her Ph.D. from Boston University, MA. 

Dr. Dunham is a member of the American Veterinary Medical Association, the American Academy of Veterinary Pharmacology and Therapeutics, the National Academies of Practice, and the American Public Health Association. She is an Honorary Diplomate and an awardee of the K.F. Meyer - James H. Steele Gold-Headed Cane Award from the American Veterinary Epidemiology Society. She has served on peer review panels for the National Academies of Science, the American Heart Association - New York State Affiliate, United States Department of Agriculture-Cooperative State Research, Education and Extension Service, Competitive Programs, and the National Institutes of Health. Dr. Dunham served as the Chairperson for the 18th Session of the Code Alimentarius Committee on Residues of Veterinary Drugs in Foods.


Brianna Skinner, DVM, MPH, DACLAM
CAPT, USPHS
Senior Regulatory Veterinarian, Office of the Commissioner, Office of Counterterrorism and Emerging Threats, FDA.

Biography:
CAPT Brianna Skinner is a Commissioned Corps officer in the U.S. Public Health Service who has also served in the U.S. Army Veterinary Corps. As a uniformed service officer, she has proudly served her country for the past 22 years within the continental United States and abroad on several humanitarian and disaster response missions. She is currently assigned to the Office of Countermeasures and Emerging Threats (OCET) at the U.S. Food and Drug Administration (FDA) where she currently serves as a Senior Regulatory Veterinarian and animal model expert for the administration of policies to facilitate the availability of safe and effective medical countermeasures against chemical, biological, radiological, nuclear agents and emerging threats. Prior to transferring to the FDA, she worked at the Centers for Disease Control and Prevention for over eleven years leading clinical operations within the vivarium, consulting with principal investigators on animal care and use with infectious disease research from biosafety levels 1 – 4, and training laboratory animal veterinarians. She earned her Doctor of Veterinary Medicine degree from Tuskegee University, her Master’s in Public Health from Benedictine University, and is board certified in laboratory animal medicine with the American College of Laboratory Animal Medicine.

To Register:
FDA Employees (LMS):
https://lms.learning.hhs.gov/Saba/Web/Main/goto/RegisterCatalog?offeringId=class000000000154493&oneClickLearningON=true

Webcast Registration:

To register for the webcast, please click the link below and then follow the instructions on the registration page. After you register you will receive a link via email to access the live webinar. You must log in with your username and password which you create when you register. Please pre-register at least one day before the event to ensure you receive the access link email and outlook invitation for the session.

Register here: https://collaboration.fda.gov/fdagrandroundsjune1120reg/event/registration.html

For technical assistance please contact Jeffery.Rexrode@fda.hhs.gov.